187 related articles for article (PubMed ID: 28591733)
1. ABCG2 downregulation in glioma stem cells enhances the therapeutic efficacy of demethoxycurcumin.
Chen L; Shi L; Wang W; Zhou Y
Oncotarget; 2017 Jun; 8(26):43237-43247. PubMed ID: 28591733
[TBL] [Abstract][Full Text] [Related]
2. Demethoxycurcumin was prior to temozolomide on inhibiting proliferation and induced apoptosis of glioblastoma stem cells.
Shi L; Fei X; Wang Z
Tumour Biol; 2015 Sep; 36(9):7107-19. PubMed ID: 25877753
[TBL] [Abstract][Full Text] [Related]
3. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.
Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S
Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911
[TBL] [Abstract][Full Text] [Related]
4. Low-Dose DMC Significantly Enhances the Effect of TMZ on Glioma Cells by Targeting Multiple Signaling Pathways Both In Vivo and In Vitro.
Shi L; Sun G
Neuromolecular Med; 2015 Dec; 17(4):431-42. PubMed ID: 26458914
[TBL] [Abstract][Full Text] [Related]
5. Reactive oxygen species-mediated therapeutic response and resistance in glioblastoma.
Singer E; Judkins J; Salomonis N; Matlaf L; Soteropoulos P; McAllister S; Soroceanu L
Cell Death Dis; 2015 Jan; 6(1):e1601. PubMed ID: 25590811
[TBL] [Abstract][Full Text] [Related]
6. Anti-neoplastic activity of low-dose endothelial-monocyte activating polypeptide-II results from defective autophagy and G2/M arrest mediated by PI3K/Akt/FoxO1 axis in human glioblastoma stem cells.
Liu J; Liu L; Xue Y; Meng F; Li S; Wang P; Liu Y
Biochem Pharmacol; 2014 Jun; 89(4):477-89. PubMed ID: 24792437
[TBL] [Abstract][Full Text] [Related]
7. miR-145 inhibits migration and invasion of glioma stem cells by targeting ABCG2.
Shi L; Wang Z; Sun G; Wan Y; Guo J; Fu X
Neuromolecular Med; 2014 Jun; 16(2):517-28. PubMed ID: 24777293
[TBL] [Abstract][Full Text] [Related]
8. Glioma stem-like cells are less susceptible than glioma cells to sonodynamic therapy with photofrin.
Xu ZY; Li XQ; Chen S; Cheng Y; Deng JM; Wang ZG
Technol Cancer Res Treat; 2012 Dec; 11(6):615-23. PubMed ID: 22775340
[TBL] [Abstract][Full Text] [Related]
9. The ABCG2 transporter is a key molecular determinant of the efficacy of sonodynamic therapy with Photofrin in glioma stem-like cells.
Xu ZY; Wang K; Li XQ; Chen S; Deng JM; Cheng Y; Wang ZG
Ultrasonics; 2013 Jan; 53(1):232-8. PubMed ID: 22771084
[TBL] [Abstract][Full Text] [Related]
10. Curcumin decreases malignant characteristics of glioblastoma stem cells via induction of reactive oxygen species.
Gersey ZC; Rodriguez GA; Barbarite E; Sanchez A; Walters WM; Ohaeto KC; Komotar RJ; Graham RM
BMC Cancer; 2017 Feb; 17(1):99. PubMed ID: 28160777
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of ABCG2 protein inhibits migration and invasion in U251 glioma stem cells.
Gong W; Wang Z; Wan Y; Shi L; Zhou Y
Neuroreport; 2014 May; 25(8):625-32. PubMed ID: 24781949
[TBL] [Abstract][Full Text] [Related]
12. ABCG2 is required for self-renewal and chemoresistance of CD133-positive human colorectal cancer cells.
Ma L; Liu T; Jin Y; Wei J; Yang Y; Zhang H
Tumour Biol; 2016 Sep; 37(9):12889-12896. PubMed ID: 27449042
[TBL] [Abstract][Full Text] [Related]
13. Demethoxycurcumin analogue DMC-BH inhibits orthotopic growth of glioma stem cells by targeting JNK/ERK signaling.
Shi L; Sun G; Zhu H
Aging (Albany NY); 2020 Jul; 12(14):14718-14735. PubMed ID: 32710727
[TBL] [Abstract][Full Text] [Related]
14. Targeting of glioma stem-like cells with a parthenolide derivative ACT001 through inhibition of AEBP1/PI3K/AKT signaling.
Hou Y; Sun B; Liu W; Yu B; Shi Q; Luo F; Bai Y; Feng H
Theranostics; 2021; 11(2):555-566. PubMed ID: 33391492
[TBL] [Abstract][Full Text] [Related]
15. Suberoylanilide hydroxamic acid represses glioma stem-like cells.
Hsu CC; Chang WC; Hsu TI; Liu JJ; Yeh SH; Wang JY; Liou JP; Ko CY; Chang KY; Chuang JY
J Biomed Sci; 2016 Nov; 23(1):81. PubMed ID: 27863490
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of ABCG2 expression in glioblastoma cancer stem cells with miRNA-328 may decrease their chemoresistance.
Li WQ; Li YM; Tao BB; Lu YC; Hu GH; Liu HM; He J; Xu Y; Yu HY
Med Sci Monit; 2010 Oct; 16(10):HY27-30. PubMed ID: 20885358
[TBL] [Abstract][Full Text] [Related]
17. A curcumin derivative hydrazinobenzoylcurcumin suppresses stem-like features of glioblastoma cells by targeting Ca
Shin HJ; Lee S; Jung HJ
J Cell Biochem; 2019 Apr; 120(4):6741-6752. PubMed ID: 30390339
[TBL] [Abstract][Full Text] [Related]
18. Demethoxycurcumin Suppresses Human Brain Glioblastoma Multiforme GBM 8401 Cell Xenograft Tumor in Nude Mice
Huang YP; Ma YS; Kuo CL; Liao CL; Chen PY; Peng SF; Hsu FT; Lai KC
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071132
[TBL] [Abstract][Full Text] [Related]
19. DMC is not better than TMZ on intracranial anti-glioma effects.
Shi L; Sun G
J Cell Biochem; 2018 Jul; 119(7):6057-6064. PubMed ID: 29575236
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA 145 enhances chemosensitivity of glioblastoma stem cells to demethoxycurcumin.
Qian C; Wang B; Zou Y; Zhang Y; Hu X; Sun W; Xiao H; Liu H; Shi L
Cancer Manag Res; 2019; 11():6829-6840. PubMed ID: 31440081
[No Abstract] [Full Text] [Related]
[Next] [New Search]
